| Metric | FY 2018↕ | FY 2017↕ | FY 2016↕ | FY 2015↕ | FY 2014↕ | FY 2013↕ | FY 2012↕ | FY 2011↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0.6B | $0.6B | $0.6B | $0.7B | $0.7B | $0.6B | $2.3B | $2.1B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $0.1B | $0.2B | $0.1B | $0.1B | $0.1B | $0.1B | $0.3B | $0.3B |
| Operating Income | — | — | — | — | — | — | $-0.0B | $-0.0B |
| Net Income | $-0.1B | $-0.3B | $0.2B | $0.1B | $0.1B | $0.1B | $0.0B | $0.0B |
| EPS (Basic) | $-2.60 | $-3.25 | $-1.41 | $1.78 | $0.92 | $1.23 | $-0.09 | $0.11 |
| EPS (Diluted) | $-2.60 | $-3.25 | $-1.41 | $1.75 | $0.90 | $1.21 | $-0.09 | $0.11 |
| Metric | FY 2018↕ | FY 2017↕ | FY 2016↕ | FY 2015↕ | FY 2014↕ | FY 2013↕ | FY 2012↕ | FY 2011↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $12.5B | $12.9B | $12.1B | $11.0B | $10.7B | $10.2B | $10.3B | $9.5B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $1.1B | $1.1B | $1.3B | $1.1B | $1.2B | $1.3B | $1.5B | $1.2B |
| Total Liabilities | $9.9B | $10.0B | $8.4B | $7.6B | $7.3B | $6.9B | $6.8B | $6.3B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | — | — | — | — | — | $3.3B | $3.5B | $3.2B |
| Metric | FY 2018↕ | FY 2017↕ | FY 2016↕ | FY 2015↕ | FY 2014↕ | FY 2013↕ | FY 2012↕ | FY 2011↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $-0.3B | $-0.1B | $0.5B | $0.6B | $0.6B | $0.6B | $0.5B | $0.3B |
| Investing Cash Flow | $0.7B | $0.4B | $-0.4B | $-0.5B | $-0.5B | $-0.5B | $-0.3B | $-0.2B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-0.3B | $-0.5B | $0.1B | $-0.1B | $-0.2B | $-0.2B | $0.0B | $-0.1B |